OCRELIZUMAB vs UBLITUXIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OCRELIZUMAB vs UBLITUXIMAB: Safety Overview
| Metric | OCRELIZUMAB | UBLITUXIMAB |
|---|---|---|
| Total FAERS Reports | 56,186 | 1,582 |
| Deaths Reported | 1,406 | 27 |
| Death Rate | 2.5% | 1.7% |
| Hospitalizations | 10,364 | 213 |
| Average Patient Age | 47.2 yrs | 49.7 yrs |
| % Female Patients | 72.5% | 73.4% |
| Manufacturer | Genentech, Inc. | TG Therapeutics, Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |